Table 1. Requirements for further studies to improve the evidence base on the epidemiology of SARS-CoV-2 transmission by children.
Requirement | Elaboration |
Diverse study designs | – Household studies – Seroprevalence and sero-incidence studies – Prospective cohort studies, e.g. in schools and daycares – (Cluster-) Randomized controlled trials – Case-control studies – Impact evaluation—time-series and quasi-experimental – Population surveillance studies including children – Clinical laboratory studies, including phylogenetic data – Basic laboratory and animal studies, experimental designs – Mathematical modeling studies |
Avoidance and quantitative assessment of biases | – Selection bias in recruitment of study population or stratification – Information bias from missing data or measurement error – Confounding bias from unadjusted risk factors correlated with exposure – Survivor bias from loss to follow-up – Type II errors from significance testing with low power |
Study population generalizability and representativeness | Pediatric sample must be drawn representatively from a population of interest to avoid biases and generalize inferences, and this population must be adequately described |
Consideration of biological, behavioral and contextual factors | Collection of contextual variables, including social determinants of health such as neighborhood, cultural practices and political economic factors that impact risks and behavioral responses |
Diagnostic—laboratory testing interpretation | – Understanding different diagnostic testing methods and their limitations – Distinguishing between presence of RNA and infectious virus – Recognizing the importance of the pre-analytical phase of sample collection – Statistical interpretation of test results, taking into account the test characteristics and the effect of prevalence – Correction for imperfect reference standard |